Alternative approaches to IP regulation
DavidLegge (Talk | contribs) |
|||
| Line 20: | Line 20: | ||
Stiglitz on the Medical Prize Fund [[http://www.bmj.com/cgi/content/full/333/7582/1279 BMJ]] | Stiglitz on the Medical Prize Fund [[http://www.bmj.com/cgi/content/full/333/7582/1279 BMJ]] | ||
| + | |||
| + | |||
| + | [[Intellectual Property and Pharmaceuticals|Back to IP home]]</br> | ||
| + | [[PHM_Oz_IP_Project|IP Project Page]] | ||
Revision as of 00:00, 11 July 2007
Australian Research Council, AVCC, NHMRC, DETYA, etc etc (2001). National Principles of Intellectual Property Management of Publicly Funded Research [web reference]
Chaifetz, S., et al., Closing the access gap for health innovations: an open licensing proposal for universities. 2007. Globalisation and Health 3:1, p. 1. [web link]
Universities Allied for Essential Medicines [web link]. Statement of Principles [Principles]
Report of WHO Commission on Intellectual Property Rights, Innovation and Public Health [Web link]
Brewster et al (2005) [Innovation Strategy Today]
ICRISAT Policy on IPRs [IP management]
Possible role for patent pooling in managing SARS [Patent Pooling]
Patent pools [Patent Pools]
Anti-commons in biomedical research [Anticommons]
Stiglitz on the Medical Prize Fund [BMJ]
